相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
Frank Tacke et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis
Xin Han et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Roles of nuclear receptors in hepatic stellate cells
Shiyun Pu et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
Tian Zhang et al.
CELL DEATH AND DIFFERENTIATION (2020)
Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer
Guangyan Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Mechanisms of Fibrosis Development in NASH
Robert F. Schwabe et al.
GASTROENTEROLOGY (2020)
Taurine protected As2O3-induced the activation of hepatic stellate cells through inhibiting PPARα-autophagy pathway
Zhidong Wang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress
Tianhui Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
Targeting nuclear receptors for the treatment of fatty liver disease
Naoki Tanaka et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Adiponectin regulates AQP3 via PPARα in human hepatic stellate cells
Matteo Tardelli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
Sander Kersten et al.
BIOCHIMIE (2017)
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
Samar H. Ibrahim et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Matrix metalloproteinase-1 induction by diethyldithiocarbamate is regulated via Akt and ERK/miR222/ETS-1 pathways in hepatic stellate cells
Tianhui Liu et al.
BIOSCIENCE REPORTS (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
DIABETOLOGIA (2016)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Alexandra Montagner et al.
GUT (2016)
Hepatic Fibrosis: Emerging Therapies
Scott L. Friedman
DIGESTIVE DISEASES (2015)
Challenges and Opportunities in Drug and Biomarker Development for Nonalcoholic Steatohepatitis: Findings and Recommendations From an American Association for the Study of Liver Diseases-US Food and Drug Administration Joint Workshop
Arun J. Sanyal et al.
HEPATOLOGY (2015)
PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
Sven Francque et al.
JOURNAL OF HEPATOLOGY (2015)
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
Michal Pawlak et al.
JOURNAL OF HEPATOLOGY (2015)
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
Ling Chen et al.
ONCOTARGET (2015)
The Transrepressive Activity of Peroxisome Proliferator-Activated Receptor Alpha Is Necessary and Sufficient to Prevent Liver Fibrosis in Mice
Michal Pawlak et al.
HEPATOLOGY (2014)
The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
Carla Guzman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2-and Akt-dependent mechanism
Tianhui Liu et al.
BIOSCIENCE REPORTS (2013)
Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease
Anping Chen et al.
HEPATOLOGY (2013)
Hepatic Stellate Cells and Liver Fibrosis
Juan E. Puche et al.
COMPREHENSIVE PHYSIOLOGY (2013)
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
Boris Cvek
DRUG DISCOVERY TODAY (2012)
PPAR alpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
Aina Rodriguez-Vilarrupla et al.
JOURNAL OF HEPATOLOGY (2012)
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Why is Disulfiram Superior to Acamprosate in the Routine Clinical Setting? A Retrospective Long-Term Study in 353 Alcohol-Dependent Patients
Alexander Diehl et al.
ALCOHOL AND ALCOHOLISM (2010)
Mechanism-Based Inactivation of Human CYP2E1 by Diethyldithocarbamate
Matthew Pratt-Hyatt et al.
DRUG METABOLISM AND DISPOSITION (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
Matteo Ricchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Hepatic stellate cell line modulates lipogenic transcription factors
Eduardo L. M. Guimaraes et al.
LIVER INTERNATIONAL (2007)
Adipogenic transcriptional regulation of hepatic stellate cells
HY She et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
T Toyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture
GH Buniatian
CELL PROLIFERATION (2003)
Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies
R Kirsch et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
分享论文
